Kappos L - Search Results

1

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study.

Kappos L, Gold R, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Sarda SP, Agarwal S, Zhang A, Sheikh SI, Seidman E, Dawson KT. Kappos L, et al. Mult Scler. 2014 Feb;20(2):243-52. doi: 10.1177/1352458513507817. Epub 2013 Oct 22. Mult Scler. 2014. PMID: 24150779 Clinical Trial.

2

[Facial myokymia caused by pontine lesions and central fever in multiple sclerosis--case report].

Gold R, Kappos L. Gold R, et al. Among authors: kappos l. Schweiz Rundsch Med Prax. 1991 Nov 19;80(47):1327-9. Schweiz Rundsch Med Prax. 1991. PMID: 1957099 German.

3

Development of multiple sclerosis in patient on long-term sulfasalazine.

Gold R, Kappos L, Becker T. Gold R, et al. Among authors: kappos l. Lancet. 1990 Feb 17;335(8686):409-10. doi: 10.1016/0140-6736(90)90239-2. Lancet. 1990. PMID: 1968133 No abstract available.

4

[Multiple sclerosis and its delimitation from other diseases. Case report examples with differential diagnostic considerations].

Gold R, Schuknecht B, Kappos L. Gold R, et al. Among authors: kappos l. Med Klin (Munich). 1990 Jul 15;85(7):454-8. Med Klin (Munich). 1990. PMID: 2385212 German. No abstract available.

5

Treatment of multiple sclerosis with 15 +/- deoxyspergualin. Design of a controlled study with close MRI-monitoring.

Kappos L, Radü EW, Bernasconi L, Brunnschweiler H, Hartung HP, Haas J, Gehlen W, Hartard C, Lagreze HL, Rüttinger H, et al. Kappos L, et al. Schweiz Arch Neurol Psychiatr (1985). 1993;144(3):198-201. Schweiz Arch Neurol Psychiatr (1985). 1993. PMID: 7687364 Clinical Trial.

6

Intravenous immunoglobulin (IVIG) treatment for patients with primary or secondary progressive multiple sclerosis -- outline of a double-blind randomized, placebo-controlled trial.

Poehlau D, Federlein J, Postert T, Sailer M, Bethke F, Kappos L, Haas J, Przuntek H. Poehlau D, et al. Among authors: kappos l. Mult Scler. 1997 Apr;3(2):149-52. doi: 10.1177/135245859700300217. Mult Scler. 1997. PMID: 9291171 Clinical Trial.

7

Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.

Polman CH, Dahlke F, Thompson AJ, Ghazi M, Kappos L, Miltenburger C, Pozilli C. Polman CH, et al. Among authors: kappos l. Mult Scler. 1995;1 Suppl 1:S51-4. Mult Scler. 1995. PMID: 9345400 Clinical Trial.

8

Interferon beta in the treatment of multiple sclerosis--closing remarks.

Kappos L. Kappos L. Mult Scler. 1995;1 Suppl 1:S64-6. Mult Scler. 1995. PMID: 9345403 Review. No abstract available.

9

Combinations of drugs.

Kappos L. Kappos L. Mult Scler. 1996 Jul;1(6):400-3. doi: 10.1177/135245859600100624. Mult Scler. 1996. PMID: 9345426

10

Computer assisted retraining of attentional impairments in patients with multiple sclerosis.

Plohmann AM, Kappos L, Ammann W, Thordai A, Wittwer A, Huber S, Bellaiche Y, Lechner-Scott J. Plohmann AM, et al. Among authors: kappos l. J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):455-62. doi: 10.1136/jnnp.64.4.455. J Neurol Neurosurg Psychiatry. 1998. PMID: 9576535 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters